Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
National University of Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National University of Singapore, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National University of Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National University of Singapore, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
National University of Singapore, Medical Devices Deals, 2012 to YTD 2018 9
National University of Singapore, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
National University of Singapore, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Annexin Pharma Enters into Collaboration Agreement with National University of Singapore 11
Ab Sciex Enters into R&D Agreement with National University of Singapore 12
Ayoxxa Biosystems Enters Into Research Agreement With NUS For Protein Analysis Technology Development 13
Licensing Agreements 14
Proteona Enters into Licensing Agreement with National University of Singapore 14
Nkarta Enters into Licensing Agreement with National University of Singapore and Jude Children’s Research Hospital 15
MediSix Therapeutics Enters into Licensing Agreement with National University of Singapore 16
Unum Therapeutics Expands Licensing Agreement with National University of Singapore and St. Jude Children’s Research Hospital 17
National University of Singapore – Key Employees 19
National University of Singapore – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 21
Recent Developments 22
Strategy And Business Planning 22
Nov 22, 2017: SCIEX and NUS Faculty of Science Announce Plans to Launch New Training Centre for Proteomics and Mass Spectrometry Across Asia Pacific 22
Government and Public Interest 23
Oct 08, 2018: NUS researchers uncover new role of TIP60 protein in controlling tumour formation 23
Aug 16, 2018: NUS researchers uncover a bidirectional regulator and shed light on A-to-I RNA editing in cancer cells 24
Aug 16, 2018: NUS and Harvard scientists develop novel drug that could potentially treat liver cancer more effectively 25
Aug 15, 2018: NUS study: RUNX proteins act as regulators in DNA repair 27
Apr 30, 2018: NUS researchers demystify cancer-related fatigue in breast cancer patients 29
Apr 10, 2018: Early ‘chemobrain’ intervention needed for breast cancer patients undergoing chemotherapy: NUS-led study 30
Jan 30, 2018: NUS researchers develop wireless light switch for targeted cancer therapy 32
Dec 07, 2017: NUS researchers uncover novel pathway to suppress virus-induced cancers 33
Nov 13, 2017: NUS researchers unveil mystery behind workings of blood cells 34
Sep 18, 2017: NUS scientists combine antimalarial drug with light sensitive molecules for promising treatment of cancer 35
Product News 36
Aug 14, 2018: AI technology to help design personalised combination therapy 36
Mar 01, 2018: Duke-NUS commercialises discovery to deliver therapeutics across blood brain barrier 37
Appendix 38
Methodology 38
About GlobalData 38
Contact Us 38
Disclaimer 38
National University of Singapore, Pharmaceuticals & Healthcare, Key Facts 2
National University of Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National University of Singapore, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
National University of Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National University of Singapore, Deals By Therapy Area, 2012 to YTD 2018 8
National University of Singapore, Medical Devices Deals, 2012 to YTD 2018 9
National University of Singapore, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Annexin Pharma Enters into Collaboration Agreement with National University of Singapore 11
Ab Sciex Enters into R&D Agreement with National University of Singapore 12
Ayoxxa Biosystems Enters Into Research Agreement With NUS For Protein Analysis Technology Development 13
Proteona Enters into Licensing Agreement with National University of Singapore 14
Nkarta Enters into Licensing Agreement with National University of Singapore and Jude Children’s Research Hospital 15
MediSix Therapeutics Enters into Licensing Agreement with National University of Singapore 16
Unum Therapeutics Expands Licensing Agreement with National University of Singapore and St. Jude Children’s Research Hospital 17
National University of Singapore, Key Employees 19
National University of Singapore, Other Locations 20
National University of Singapore, Subsidiaries 20
National University of Singapore, Joint Venture 21
List of Figures
National University of Singapore, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
National University of Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
National University of Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
National University of Singapore, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
National University of Singapore, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
National University of Singapore, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
National University of Singapore, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
National University of Singapore, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
National University of Singapore, Medical Devices Deals, 2012 to YTD 2018 9
